INFluENZA Vaccine
Study background
Seasonal flu viruses pose a serious challenge to public health as there are 3-5 million cases of severe illness annually resulting in up to 650,000 deaths. Current flu vaccines rarely exceed 60% overall effectiveness, however flu vaccines based on new technology could provide several benefits resulting in greater effectiveness. These benefits include the ability to respond to newer strains of the virus faster and avoid mutations that could occur in vaccine development.
The flu vaccine is delivered yearly for protection against flu viruses. In this study you will either receive the new flu vaccine or a current flu vaccine.
Study Details
The study would require you to come to the clinic 2 times over 1 month. The first visit will take up to 90 mins and the second visit will take 15 mins. Over the course of the study, we will check your medical history, draw blood, and will administer the vaccine. An e-diary will also need to be completed during the study.
You will be reimbursed for your time in the research study.
Eligibility criteria
- Aged over 18 years
- Is not immunocompromised
- Has not already received a flu vaccine in the last six months
- Has not tested positive for flu in the last six months